Zn/Na Co-Doped Hydroxyapatites: Synthesis, Antibacterial, and Bioactivity Studies

dc.contributor.author Samadi, Hamed
dc.contributor.author Pakchin, Parvin Samadi
dc.contributor.author Mohammadpourfard, Mousa
dc.contributor.author Adibkia, Khosro
dc.date.accessioned 2025-06-25T20:47:09Z
dc.date.available 2025-06-25T20:47:09Z
dc.date.issued 2025
dc.description.abstract The most crucial challenge of post-orthopedic surgery is related to bacterial film formation, which leads to implant failure. In this work, zinc/sodium (Zn/Na) co-doped hydroxyapatite nanoparticles (HA NPs) with different Zn/Na concentrations, including 1, 3, and 5 mol.% were synthesized using a hydrothermal method. Several analyses such as X-ray Diffraction (XRD), Fourier Transform Infrared Spectroscopy (FTIR), Energy Dispersive X-ray Spectroscopy (EDX), Scanning Electron Microscopy (SEM), and N2 ad/desorption were used to pinpoint the properties of as-prepared materials. Field Emission Scanning Electron Microscopy (FE-SEM) and EDX analysis demonstrated that the HA NPs possess an average size of about 30-40 nm and hexagonal morphology with no impurity. XRD patterns confirm that by the increasing amounts of Zn/Na, the crystal size of samples was decreased. FT-IR affirms the correct doping of metal ions. Brunauer-Emmett-Teller (BET) results of co-doped samples demonstrated a microporous structure, which can improve fluid flow in the inner structure of implants. The colony-forming unit (CFU) method conducted the antibacterial test, which confirmed that 5 mol.% Zn/Na co-doped HA NPs showed the highest antibacterial properties against Escherichia coli (PTCC 1276) (E. coli). Cytotoxicity results affirmed that 1 and 3mol.% Zn/Na co-doped HA NPs demonstrated low toxicity. Bioactivity tests revealed that the Zn/Na co-doped samples showed a higher ability to facilitate bone marrow stem cells; thus, improving the proliferation after the immersion in simulated body fluid (SBF). Therefore, Zn/Na co-doped HA NPs could be a promising candidate for bone tissue engineering applications. en_US
dc.description.sponsorship Tabriz University [14009833702] en_US
dc.description.sponsorship This research was a part of a MSc. Thesis (project number, 14009833702) approved at Tabriz University and performed at RCPN as a joint project. en_US
dc.identifier.doi 10.1016/j.matchemphys.2025.130833
dc.identifier.issn 0254-0584
dc.identifier.issn 1879-3312
dc.identifier.scopus 2-s2.0-105002644427
dc.identifier.uri https://doi.org/10.1016/j.matchemphys.2025.130833
dc.identifier.uri https://hdl.handle.net/11147/15596
dc.language.iso en en_US
dc.publisher Elsevier Science Sa en_US
dc.relation.ispartof Materials Chemistry and Physics
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Antibacterial Efficiency en_US
dc.subject Bioactivity en_US
dc.subject Hydroxyapatite Nps en_US
dc.subject Metal Co-Doping en_US
dc.title Zn/Na Co-Doped Hydroxyapatites: Synthesis, Antibacterial, and Bioactivity Studies en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.wosid Mohammadpourfard, Mousa/Jan-7488-2023
gdc.author.wosid Adibkia, Khosro/E-3205-2017
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department İzmir Institute of Technology en_US
gdc.description.departmenttemp [Samadi, Hamed; Mohammadpourfard, Mousa] Univ Tabriz, Fac Chem & Petr Engn, Dept Chem Engn, Tabriz, Iran; [Samadi, Hamed; Pakchin, Parvin Samadi; Adibkia, Khosro] Tabriz Univ Med Sci, Biomed Inst, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran; [Mohammadpourfard, Mousa] Izmir Inst Technol, Dept Energy Syst Engn, Izmir, Turkiye; [Adibkia, Khosro] Tabriz Univ Med Sci, Fac Pharm, Tabriz, Iran en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q1
gdc.description.volume 341 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q2
gdc.identifier.openalex W4409146737
gdc.identifier.wos WOS:001474002400001
gdc.index.type WoS
gdc.index.type Scopus
gdc.oaire.diamondjournal false
gdc.oaire.impulse 4.0
gdc.oaire.influence 2.729452E-9
gdc.oaire.isgreen false
gdc.oaire.popularity 2.139348E-10
gdc.oaire.publicfunded false
gdc.openalex.fwci 9.96430904
gdc.openalex.normalizedpercentile 0.94
gdc.openalex.toppercent TOP 10%
gdc.opencitations.count 0
gdc.plumx.crossrefcites 1
gdc.plumx.mendeley 5
gdc.plumx.scopuscites 4
gdc.scopus.citedcount 4
gdc.wos.citedcount 4
relation.isAuthorOfPublication.latestForDiscovery c8864ec8-be75-470d-b4e3-cb3d09ec1dc1
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4017-8abe-a4dfe192da5e

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Name:
1-s2.0-S0254058425004791-main.pdf
Size:
9.49 MB
Format:
Adobe Portable Document Format
Description:
Article